These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 23128378)
21. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells. Mijatovic S; Maksimovic-Ivanic D; Mojic M; Timotijevic G; Miljkovic D; Mangano K; Donia M; Di Cataldo A; Al-Abed Y; Cheng KF; Stosic-Grujicic S; Nicoletti F J Cell Physiol; 2011 Jul; 226(7):1803-12. PubMed ID: 21506111 [TBL] [Abstract][Full Text] [Related]
22. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
23. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance. Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648 [TBL] [Abstract][Full Text] [Related]
24. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734 [TBL] [Abstract][Full Text] [Related]
25. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689 [TBL] [Abstract][Full Text] [Related]
26. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft. Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274 [TBL] [Abstract][Full Text] [Related]
27. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice]. Dai M; Luo RC; Zheng DY; Lü CW; Ding XM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788 [TBL] [Abstract][Full Text] [Related]
28. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1. Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223 [TBL] [Abstract][Full Text] [Related]
29. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
30. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth. Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299 [TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations. Zhang XH; Shin JY; Kim JO; Oh JE; Yoon SA; Jung CK; Kang JH Cancer Lett; 2012 Sep; 322(2):213-22. PubMed ID: 22433711 [TBL] [Abstract][Full Text] [Related]
32. Combined liposome-mediated cytosine deaminase gene therapy with radiation in killing rectal cancer cells and xenografts in athymic mice. Li S; Yu B; An P; Chen G; Lu W; Cai H; Guo W; Zuo F Clin Cancer Res; 2005 May; 11(9):3574-8. PubMed ID: 15867262 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022 [TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer. Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188 [TBL] [Abstract][Full Text] [Related]
35. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Nishizaki M; Meyn RE; Levy LB; Atkinson EN; White RA; Roth JA; Ji L Clin Cancer Res; 2001 Sep; 7(9):2887-97. PubMed ID: 11555607 [TBL] [Abstract][Full Text] [Related]
36. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice. Lee I; Kalota A; Gewirtz AM; Shogen K Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247 [TBL] [Abstract][Full Text] [Related]
37. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo. Gu J; Tang Y; Liu Y; Guo H; Wang Y; Cai L; Li Y; Wang B Cancer Lett; 2014 Feb; 343(2):200-9. PubMed ID: 24161623 [TBL] [Abstract][Full Text] [Related]
38. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt. Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251 [TBL] [Abstract][Full Text] [Related]
39. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1. Deng WG; Wu G; Ueda K; Xu K; Roth JA; Ji L Cancer Gene Ther; 2008 Jan; 15(1):29-39. PubMed ID: 17828283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]